Arcellx (ACLX) Asset Utilization Ratio (2023 - 2025)

Arcellx's (ACLX) quarterly Asset Utilization Ratio came in at 0.04 in Q4 2025, down 75.72% year-on-year from 0.15 in Q4 2024, and down 37.04% quarter-over-quarter from 0.06 in Q3 2025.

Arcellx (ACLX) Asset Utilization Ratio (2023 - 2025) Analysis & Trends

Arcellx's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.04 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 75.72% year-over-year to 0.04 in Q4 2025; TTM through Dec 2025 was 0.04, a 75.72% decrease from a year earlier, with the FY2025 full-year figure at 0.03, down 75.88% from the prior year.
  • Asset Utilization Ratio fell to 0.04 in Q4 2025 per ACLX's latest filing, from 0.06 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.21 in Q3 2024 and bottomed at 0.04 in Q4 2025.
  • The 3-year median for Asset Utilization Ratio is 0.1 (2025), against an average of 0.11.
  • Across the five-year window, Asset Utilization Ratio soared 329.06% in 2024 and tumbled 75.72% in 2025, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.15 in 2023, then decreased by 4.6% to 0.15 in 2024, then tumbled by 75.72% to 0.04 in 2025.
  • Per Business Quant, the three latest ACLX Asset Utilization Ratio figures stand at 0.04 (Q4 2025), 0.06 (Q3 2025), and 0.09 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - 0.04

Historic Data

Download Data
DateValue
Dec 31, 2025 0.04
Sep 30, 2025 0.06
Jun 30, 2025 0.09
Mar 31, 2025 0.11
Dec 31, 2024 0.15
Sep 30, 2024 0.21
Jun 30, 2024 0.19
Mar 31, 2024 0.16
Dec 31, 2023 0.15
Sep 30, 2023 0.08
Jun 30, 2023 0.05
Mar 31, 2023 0.04